Literature DB >> 8174710

Annexin-I inhibits phospholipase A2 by specific interaction, not by substrate depletion.

K M Kim1, D K Kim, Y M Park, C K Kim, D S Na.   

Abstract

Annexin-I is a calcium dependent phospholipid binding and phospholipase A2 (PLA2) inhibitory protein. A 'substrate depletion' model has been proposed for the mechanism of PLA2 inhibition by annexin-I in studies with 14 to 18 kDa PLA2s. Herein, we have studied the inhibition mechanism using 100 kDa cytosolic PLA2 from porcine spleen. The inhibition has been measured at various substrate and calcium ion concentrations. The pattern of PLA2 inhibition by annexin-I was consistent with a 'specific interaction' mechanism rather than the 'substrate depletion' model. Apparent contraction with previous studies can be explained by the calcium-dependent binding of annexin-I to the substrate.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8174710     DOI: 10.1016/0014-5793(94)80566-0

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  25 in total

Review 1.  The regulation of neurotransmitter secretion by protein kinase C.

Authors:  P F Vaughan; J H Walker; C Peers
Journal:  Mol Neurobiol       Date:  1998-10       Impact factor: 5.590

2.  Defining the structural characteristics of annexin V binding to a mimetic apoptotic membrane.

Authors:  Jingxiong Lu; Anton P Le Brun; Seong Hoong Chow; Takuya Shiota; Bo Wang; Tsung-Wu Lin; Guei-Sheung Liu; Hsin-Hui Shen
Journal:  Eur Biophys J       Date:  2015-08-14       Impact factor: 1.733

3.  Cross-linking of glycosphingolipids at the plasma membrane: consequences for intracellular signaling and traffic.

Authors:  Tove Irene Klokk; Simona Kavaliauskiene; Kirsten Sandvig
Journal:  Cell Mol Life Sci       Date:  2015-09-25       Impact factor: 9.261

Review 4.  Fifteenth Gaddum Memorial Lecture December 1994. Stress and the neuroendocrine-immune axis: the pivotal role of glucocorticoids and lipocortin 1.

Authors:  J C Buckingham
Journal:  Br J Pharmacol       Date:  1996-05       Impact factor: 8.739

5.  Evidence for specific annexin I-binding proteins on human monocytes.

Authors:  N J Goulding; L Pan; K Wardwell; V C Guyre; P M Guyre
Journal:  Biochem J       Date:  1996-06-01       Impact factor: 3.857

6.  Annexin V autoantibodies in rheumatoid arthritis.

Authors:  M I Rodríguez-García; J A Fernández; A Rodríguez; M P Fernández; C Gutierrez; J C Torre-Alonso
Journal:  Ann Rheum Dis       Date:  1996-12       Impact factor: 19.103

7.  Proteomic study of granulocytic differentiation induced by apigenin 7-glucoside in human promyelocytic leukemia HL-60 cells.

Authors:  Eri Nakazaki; Soninkhishig Tsolmon; Junkyu Han; Hiroko Isoda
Journal:  Eur J Nutr       Date:  2011-11-24       Impact factor: 5.614

8.  Effect of annexin-1 on experimental autoimmune encephalomyelitis (EAE) in the rat.

Authors:  I Huitinga; J Bauer; P J Strijbos; N J Rothwell; C D Dijkstra; F J Tilders
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

9.  Glucocorticoid inhibition of adjuvant arthritis synovial macrophage nitric oxide production: role of lipocortin 1.

Authors:  Y H Yang; P Hutchinson; L L Santos; E F Morand
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

10.  Roles of Rac and p38 kinase in the activation of cytosolic phospholipase A2 in response to PMA.

Authors:  Hye Jin You; Chang-Hoon Woo; Eun-Young Choi; Sung-Hoon Cho; Yung Joon Yoo; Jae-Hong Kim
Journal:  Biochem J       Date:  2005-06-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.